Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making stem cell lines suitable for transplantation.

Helen Hodges1, Kenneth Pollock, Paul Stroemer

  • 1Department of Psychology, Institute of Psychiatry, Kings College, London, UK. h.hodges@iop.kcl.ac.uk

Cell Transplantation
|May 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered central vestibular processing in Parkinson's disease with Pisa syndrome.

Scientific reports·2026
Same author

Identifying the parental figures of children who enter care: The pros and cons of different data linkage methods using Welsh datasets.

International journal of population data science·2026
Same author

In vivo study to assess dosage of allogeneic pig retinal progenitor cells: Long-term survival, engraftment, differentiation and safety.

Journal of cellular and molecular medicine·2022
Same author

Age-related changes in oral sensitivity, taste and smell.

Scientific reports·2022
Same author

Engineered neural tissue made using clinical-grade human neural stem cells supports regeneration in a long gap peripheral nerve injury model.

Acta biomaterialia·2021
Same author

Improved Balance and Gait Ability and Basic Activities of Daily Living after Comprehensive Geriatric Care in Frail Older Patients with Fractures.

Healthcare (Basel, Switzerland)·2021

Developing conditionally immortal stem cell lines for CNS disorders shows promise. These clinical-grade cells divide in vitro, differentiate in vivo, and offer functional benefits for neurodegenerative disease treatments.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Human stem cells from various sources are explored for central nervous system (CNS) disorder treatments.
  • While experimental grafts show survival and functional benefits, scaling up for mass treatment under Good Manufacturing Practice (GMP) remains a challenge.
  • Continuous division of stem cells in culture offers potential for expanding production to meet clinical demands for neurodegenerative diseases.

Purpose of the Study:

  • To review the development of conditionally immortal clinical-grade stem cell lines.
  • To outline the stages, selection criteria, challenges, and successes in creating stem cell lines for therapeutic use.
  • To discuss methods for ensuring stem cell division in vitro and differentiation in vivo for CNS disorder treatments.

Main Methods:

Related Experiment Videos

  • Review of experimental studies on stem cell grafts for CNS disorders.
  • Discussion of genetic and oncogenetic manipulations for long-term stem cell culture and controlled differentiation.
  • Exemplification using murine MHP36 cell line (SV40 large T antigen) and c-mycERTAM-transfected cell lines (tamoxifen-inducible).

Main Results:

  • Conditionally immortal stem cell lines can be developed to divide in vitro and differentiate in vivo.
  • Successful examples include MHP36 and c-mycERTAM-regulated cell lines.
  • These cell lines demonstrate positive functional effects in experimental models.

Conclusions:

  • Conditionally immortal clinical-grade stem cell lines offer a scalable approach for treating CNS disorders.
  • Genetic manipulation is key to balancing in vitro proliferation with in vivo differentiation and function.
  • Further development is needed to address genetic stability and in vivo survival for widespread clinical application.